Health Care/Hospital

SWISS REJU invests in new body contouring technology, further expands Hong Kong's beauty and slimming service offerings

HONG KONG, April 8, 2022 /PRNewswire/ -- Wellness and beauty brand SWISS REJU  recently announced further investment in new beauty technology, introducing cutting edge, top of the market European slimming machines to theHong Kong market.  SWISS REJU, located at the heart of ...

2022-04-08 08:00 2146

New very-high-sensitivity rapid antigen test kits hit Australian market

New COVID-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available inAustralia MELBOURNE, Australia, April 8, 2022 /PRNewswire/ -- Medriva; https://medriva.com , a leading global manufacturer of COVID-19 testing and vaccination products, announced the Aus...

2022-04-08 06:00 2578

Henlius' Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer

SHANGHAI, April 7, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the United States Food and Drug Administration (FDA) has granted Orphan-Drug Designation (ODD) for HANSIZHUANG (serplulimab) for the treatment of small cell lung cancer (SCLC). This is the first such d...

2022-04-07 22:21 2738

SIMCERE PHARMA (HK.2096) to host 2022 R&D Day

HONG KONG, April 7, 2022 /PRNewswire/ -- SIMCERE PHARMA (HK.2096), an innovation and R&D-driven pharmaceutical company with a mission of "providing today's patients with medicines of the future", will host a virtual R&D Day, on Friday,15 April, 2022, at 21:00-23:00 (HKT) / 9:00-11:00 (EST) / 13:0...

2022-04-07 21:39 2278

Contract Development and Manufacturing Organizations Shifting Focus to Meet Future Demand

An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines SAN ANTONIO, April 7, 2022 /PRNewswire/ -- Transformational forces are influencing the global contract development and manufacturing ...

2022-04-07 18:01 1490

Asset Visibility Market Opportunity in the Pharmaceutical Industry Worth US$2.7 Billion by 2026

IoT technologies contribute to rapidly expanding market for safeguarding goods as well as improving enterprises' bottom line LONDON, April 7, 2022 /PRNewswire/ -- Pharmaceutical manufacturers, distributors, and transportation providers all face unique pain points within their supply chain operat...

2022-04-07 16:00 1626

Therapy Pro wins at the 2022 Australian Disability Service Awards

* Therapy Pro has been recognised at the Australian Disability Service Awards for their innovative program offerings and positive exceptional outcomes. * Claiming "Best Early Intervention Program", the award was received by Managing DirectorPhil Laidlaw. * The Australian Disability Awards sa...

2022-04-07 12:33 1886

Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics

- Funding from long-term investors to build leading delivery platform and scalable drug discovery engine to enable modular and programmable medicines - Company is harnessing the potential of RNA therapeutics to deliver medicines to liver and extrahepatic tissues with specific, stable and prolonge...

2022-04-07 12:30 2413

BIO KOREA, Asia's Biggest Bio-Health Convention, to Open in May 2022

Global Event to Kick off as the Post-COVID Era Begins in Earnest, with Theme  "Beyond the Pandemic, into a Next Wave" SEOUL, South Korea, April 7, 2022 /PRNewswire/ --Initiated in 2006, BIO KOREA is the biggest bio-health convention inAsia that is dedicated to promoting the international standin...

2022-04-07 10:14 2338

Team Nana Shilpa from Sri Lanka crowned Asia winner for Microsoft's 2022 Imagine Cup World Finals

* Team Nana Shilpa, the winner of the Health category in Asia, will advance to Microsoft's Imagine Cup World Championships inMay 2022 * The other three category winners in Asia include Team Three Stooges and One Master from China for the Earth category, Team Laze Project from Japan for the Ed...

2022-04-07 10:00 2233

Everest Medicines Enters into an MOU for Partnership with China Resources Pharmaceutical Group for its mRNA Vaccine Business

China Resources Pharmaceutical Group ("CR Pharma") intends to make strategic equity investment for Everest's mRNA technology platform Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancement of Everest's po...

2022-04-07 07:30 2641

ZEISS to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software Applications

Advancing ophthalmic care through integrated clinical workflow solutions: * Efficiency in the cataract workflow * Can help increase treatment outcome predictability in the corneal refractive workflow * Machine learning and artificial intelligence in the retina clinic JENA, Germany and DUBLI...

2022-04-06 21:00 2000

Treadwell Therapeutics and University Health Network Sign Licensing Agreement for pre-clinical biologic and small molecule assets

NEW YORK, HONG KONG and TORONTO, April 6, 2022 /PRNewswire/ -- Treadwell Therapeutics today announced that it has entered into a license agreement with the University Health Network (UHN) inToronto, Canada for four novel oncology target programs, including a deep estate of pre-clinical therapeuti...

2022-04-06 20:59 1799

Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

* Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu * Assay result of Seegene's decades-long know-how, applies DPO∙TOCE∙MuDT technologies * "Optimal solution for safe return to normalcy as distancing restrictions eased" SEOUL, South Korea, April 6...

2022-04-06 20:08 1982

Antengene's Pivotal "MARCH" Study to Evaluate Selinexor (ATG-010) in Relapsed or Refractory Multiple Myeloma Published in BMC Medicine

- Results showed an overall response rate (ORR) of 29.3% for all treated patients. - Consistent responses across all risk groups, including patients who received prior "triple-class" and CAR-T therapies or having cytogenetic abnormalities. - Selinexor is on track for a Q2:22 launch in China. SHAN...

2022-04-06 20:03 2589

Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative

MANASSAS, Va., April 6, 2022 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-based epidemiology centers of excellence. The new centers...

2022-04-06 19:37 2330

Ascletis Announces China IND Approval of Its Second FASN Inhibitor ASC60 for Treatment of Advanced Solid Tumors

HANGZHOU, China and SHAOXING, China, April 6, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that the Investigational New Drug (IND) application of its second fatty acid synthase (FASN) inhibitor ASC60 for treatment of advanced solid tumors has been approved by China ...

2022-04-06 17:10 2176

Alex Therapeutics raises €3.5M in oversubscribed financing round from top tier VC investors to advance expansion in Europe and the US.

STOCKHOLM, April 6, 2022 /PRNewswire/ -- Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics today announces it has secured a€3.5M funding round, led by European life science venture fund Hadean Ventures and joined by Scale Capital and Bonit Capital. Alex Therapeutics aspires to...

2022-04-06 14:20 1585

Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy

SAN FRANCISCO and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2022-04-06 12:43 2887

VISTA Eye Specialist (VISTA) introduces cutting-edge Swiss Technology for Cataract Surgery, giving patients a simple, fast and safe procedure.

PETALING JAYA, Malaysia, April 6, 2022 /PRNewswire/ -- VISTA is always looking to provide the latest technology availablefor Cataract patients - making the surgery simpler and improve the result, safety and comfort - not just for the patient but also the surgeon. Having Robotic Computer-aided tec...

2022-04-06 09:11 2407
1 ... 210211212213214215216 ... 553